Grade E07: £41,064 – £48,822 per annum pro‑rated if part‑time.
Contract: fixed‑term, 24 months (to 30 Apr 2028). Full‑time: 35 hours per week. Flexible part‑time and hybrid working arrangements available.
Opportunity
This post‑doctoral researcher will join a dynamic, funded project “Nucleoli, inflammation and cancer risk: does size matter?” in the Stark laboratory at the University of Edinburgh. The lab focuses on the interplay between ageing, nucleoli, inflammation and cancer, bridging fundamental molecular biology and translational research. You will conduct multiplex immunohistochemistry on human and animal cohorts, perform phenotypic assays, and execute molecular analyses to uncover mechanistic links at the heart of age‑associated nucleolar changes and cancer risk.
The project is now moving into a discovery phase where you will shape the mechanistic direction of the work, identify biomarkers and interventions relevant to ageing populations, and contribute discoveries with transformative translational impact.
Your skills and attributes for success
* A PhD in cancer biology, molecular biology, biochemistry or a closely related discipline.
* Expertise in the molecular dissection of cancer cell signalling pathways.
* Experience with molecular and cellular biology techniques, including quantitative imaging and image analysis.
* Proficiency in data analysis and bioinformatics relevant to signalling studies.
* Strong interpersonal and communication skills, and a record of collaborative work in multidisciplinary teams.
* Demonstrated initiative and independence in managing research projects, with excellent organisational and project‑management skills.
* A developing track record of high‑quality research outputs, evidenced by rigorous, interdisciplinary scholarship.
The successful candidate will develop a strong research profile and be positioned for the next step in an academic career. This role is full‑time but part‑time or flexible arrangements are considered.
#J-18808-Ljbffr